title: MCP-1 and MIP-2 response in Trichinella spiralis infected mice treated with 4-deoxypyridoxine (4-DPD).
abstract: Chemokines are involved in a number of pathophysiological conditions, such as inflammatory processes and are divided in two major subfamilies, C-X-C and C-C chemokines. The C-C chemokines are monocyte chemotactic protein 1-2-3-4-5, while C-X-C chemokines include MIP-2, IL-8, etc. We studied the levels of MCP-1 and MIP-2 in diaphragmatic and intercostal muscle tissue and serum in Trichinella spiralis infected mice treated and not treated with 4-deoxypyridoxine, a potent Vit. B6 antagonist which inhibits humoral and cellular immune response. MCP-1 and MIP-2 were measured in homogenized tissue and serum and determined by a specific ELISA. Here we found the levels of MCP-1 and MIP-2 in diaphragmatic and intercostal muscle tissue of T. spiralis infected mice were significantly increased after 10 days and peaked on day 20 post-infection; however, the levels of MIP-2 in mice treated with 4-DPD was lower than that of untreated mice at day 20. MCP-1 also peaked at days 20 and 40. Animals treated with 4-DPD also inhibited the production of MCP-1, compared with untreated animals. The maximum inhibition was at day 40. These inhibitory effects on MIP-2 and MCP-1 were also repeated in the serum determinations, but were not significant. This study demonstrates that MIP-2 and MCP-1 are stimulated in serum and tissue of T. spiralis infected mice and 4-DPD-treated animals significantly inhibited them.
authors.affiliation: Department of Parasitology, Veterinary Faculty, Aristotle University of Thessaloniki, Thessaloniki, Greece. frydas@vet.auth.gr
authors.forename: Stavros
authors.initials: S
authors.lastname: Frydas
authors.forename: Nicolaos
authors.initials: N
authors.lastname: Papaioannou
authors.forename: Marcella
authors.initials: M
authors.lastname: Reale
authors.forename: Renato C
authors.initials: RC
authors.lastname: Barbacane
authors.forename: Pio
authors.initials: P
authors.lastname: Conti
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D018932:Chemokine CCL2 / Q000378:metabolism*; D054426:Chemokine CXCL2; D018925:Chemokines / Q000378:metabolism*; D003964:Diaphragm / Q000378:metabolism / Q000473:pathology; D007366:Intercostal Muscles / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011736:Pyridoxine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D017160:Trichinella spiralis / Q000276:immunology*; D014235:Trichinellosis / Q000276:immunology*; D015854:Up-Regulation
chemical_list: D000893:Anti-Inflammatory Agents; D018932:Chemokine CCL2; D054426:Chemokine CXCL2; D018925:Chemokines; C404915:Cxcl2 protein, mouse; C004675:4-deoxypyridoxine; D011736:Pyridoxine